Generation and characterization of Japanese encephalitis virus expressing GFP reporter gene for high throughput drug screening
Zhe-Rui Zhang,Hong-Qing Zhang,Xiao-Dan Li,Cheng-Lin Deng,Zhen Wang,Jia-Qi Li,Na Li,Qiu-Yan Zhang,Hong-Lei Zhang,Bo Zhang,Han-Qing Ye
DOI: https://doi.org/10.1016/j.antiviral.2020.104884
IF: 7.6
2020-10-01
Antiviral Research
Abstract:<p>Japanese encephalitis virus (JEV), a major cause of Japanese encephalitisis, is an arbovirus that belongs to the genus <em>Flavivirus</em> of the family <em>Flaviviridae</em>. Currently, there is no effective drugs available for the treatment of JEV infection. Therefore, it is important to establish efficient antiviral screening system for the development of antiviral drugs. In this study, we constructed a full-length infectious clone of eGFP-JEV reporter virus by inserting the eGFP gene into the capsid-coding region of the viral genome. The reporter virus RNA transfected-BHK-21 cells generated robust eGFP fluorescence signals that were correlated well with viral replication. The reporter virus displayed growth kinetics similar to wild type (WT) virus although replicated a little slower. Using a known JEV inhibitor, NITD008, we demonstrated that the reporter virus could be used to identify inhibitors against JEV. Furthermore, an eGFP-JEV-based high throughput screening (HTS) assay was established in a 96-well format and used for screening of 1,443 FDA-approved drugs. Sixteen hit drugs were identified to be active against JEV. Among them, five compounds which are lonafarnib, cetylpyridinium chlorid, cetrimonium bromide, nitroxoline and hexachlorophene, are newly discovered inhibitors of JEV, providing potential new therapies for treatment of JEV infection.</p>
pharmacology & pharmacy,virology